Discover
MANE
Veradermics, Incorporated
109.24
100 x undefined
200 x undefined
bid
ask
+
2.49
2.33%
10:25 AM
timesize
| Ytd | 189.38% | |
| 1y | 189.38% |
105.40
day range
109.87
32.00
52 week range
131.24
| Open | 107.44 | Prev Close | 106.75 | Low | 105.40 | High | 109.87 | Mkt Cap | 4.56B |
| Vol | 42.67K | Avg Vol | 772.02K | EPS | -2.50 | P/E | N/A | Forward P/E | -39.69 |
| Beta | N/A | Short Ratio | 5.02 | Inst. Own | 98.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 106.50 | 200-d Avg | 88.15 | 1yr Est | 163.50 |
| Income Statement | |||
| Operating Expenses | 29.55M | ||
| Research and Development Expense | 18.61M | ||
| Selling, General and Administrative Expense | 10.95M | ||
| Operating Income | -29.55M | ||
| Net Income | -23.50M | ||
| Net Income Common Stock | -23.50M | ||
| Net Income Common Stock (USD) | -23.50M | ||
| Consolidated Income | -23.50M | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.58 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -23.50M | ||
| Earning Before Interest & Taxes (USD) | -23.50M | ||
| Weighted Average Shares | 40.44M | ||
| Weighted Average Shares Diluted | 40.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 319.33M | ||
| Cash and Equivalents (USD) | 319.33M | ||
| Investments | 500.56M | ||
| Investments Current | 500.56M | ||
| Current Assets | 824.75M | ||
| Property, Plant & Equipment Net | 989.00K | ||
| Total Assets | 825.74M | ||
| Total Debt | 428.00K | ||
| Current Liabilities | 11.69M | ||
| Debt Non-Current | 428.00K | ||
| Total Liabilities | 12.12M | ||
| Accumulated Retained Earnings (Deficit) | -174.15M | ||
| Accumulated Other Comprehensive Income | -895.00K | ||
| Shareholders Equity | 813.61M | ||
| Shareholders Equity (USD) | 813.61M | ||
| Assets Non-Current | 989.00K | ||
| Total Debt (USD) | 428.00K | ||
| Liabilities Non-Current | 428.00K | ||
| Trade and Non-Trade Payables | 5.92M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 442.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 150.92M | ||
| Capital Expenditure | -21.00K | ||
| Issuance (Purchase) of Equity Shares | 414.58M | ||
| Net Cash Flow from Investing | -277.29M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -277.27M | ||
| Net Cash Flow from Operations | -14.49M | ||
| Share Based Compensation | 3.52M | ||